Active-ingredient Dossier
Metformin Hydrochloride
Active-ingredient Dossier for Metformin Hydrochloride (oral antidiabetic agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: APX-METFORMIN
- Brand: ARX-VILDAGLIPTIN/METFORMIN
- Brand: DIAFORMIN
- Brand: JANUMET
- Brand: KOMBIGLYZE XR
- Brand: NESINA
- Therapeutic area: Endocrinology
What is
Metformin Hydrochloride Metformin Hydrochloride is an oral antidiabetic agent.
Australian brands containing
Metformin Hydrochloride — APO-METFORMIN — APX-METFORMIN — DIAFORMIN — METFORMIN SANDOZ — GALVUMET — XIGDUO XR — ARX-VILDAGLIPTIN/METFORMIN — DIABEX — DIAFORMIN ALPHAPHARM XR — DIAXEMET XR — FORMET — GLUCOBETE
Therapeutic areas
Metformin Hydrochloride is registered in Endocrinology (53 brands) and Cardiology (5 brands).
Sponsor landscape
The ingredient is marketed by six sponsors: Arrotex Pharmaceuticals, Strides Pharma Science, Ipca Pharma, Alphapharm, Medreich, and Accord Healthcare.
PBS and regulatory activity
Four brands containing Metformin Hydrochloride are listed on the PBS, with the latest schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 March 2016, and the latest AusPAR is from 11 July 2014.